Abstract |
The aim of this study was to develop both a physical and a chemical protection of the anticancer drug gemcitabine, which suffers from a rapid plasmatic metabolization. For this purpose, we used a series of lipophilic derivatives of gemcitabine in which an acyl chain is covalently coupled to the 4-amino group of gemcitabine; moreover, a physical protection of the drug was attempted by incorporating these lipophilic derivatives into poly(H(2)NPEGCA-co-HDCA) nanospheres and nanocapsules. Nanoparticles were prepared by nanoprecipitation of the poly(H(2)NPEGCA-co-HDCA) copolymer and their size, zeta potential and encapsulation efficiency were further characterized. These results have been relied on lipophilicity and flexibility studies. Data showed that only the more lipophilic derivative, 4-(N)-stearoylgemcitabine, was incorporated with a high yield. Thus, 4-(N)-stearoylgemcitabine-containing nanospheres and nanocapsules were further analyzed by differential scanning calorimetry. Their cytotoxicity was tested on two human cancer cell lines and compared to that of gemcitabine and free 4-(N)-stearoylgemcitabine.
|
Authors | Barbara Stella, Silvia Arpicco, Flavio Rocco, Véronique Marsaud, Jack-Michel Renoir, Luigi Cattel, Patrick Couvreur |
Journal | International journal of pharmaceutics
(Int J Pharm)
Vol. 344
Issue 1-2
Pg. 71-7
(Nov 01 2007)
ISSN: 0378-5173 [Print] Netherlands |
PMID | 17651931
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 4-(N)-stearoylgemcitabine
- Antimetabolites, Antineoplastic
- Cyanoacrylates
- Nanocapsules
- Polymers
- Prodrugs
- poly(aminopoly(ethylene glycol) cyanoacrylate-co-hexadecyl cyanoacrylate)
- Deoxycytidine
- Gemcitabine
|
Topics |
- Antimetabolites, Antineoplastic
(chemistry, pharmacology)
- Calorimetry, Differential Scanning
- Cell Line, Tumor
- Cyanoacrylates
- Deoxycytidine
(analogs & derivatives, chemistry, pharmacology)
- Drug Compounding
- Drug Delivery Systems
- Humans
- Nanocapsules
- Nanospheres
- Polymers
- Prodrugs
(chemistry)
- Structure-Activity Relationship
- Gemcitabine
|